USPTO serial 79350028
TRINOMAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 13, 2024
- Examiner
- FLETCHER, TRACY L
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TRINOMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Zhuhai Trinomab Pharmaceutical Co., Ltd.
CN
Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scot A. Duvall
Scot A. Duvall STITES & HARBISON PLLC250 W. Main Street, Suite 2300Lexington, KY 40507United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Retail store services and wholesale distributorship services featuring veterinary pharmaceutical preparations; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale distributorship services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services and wholesale distributorship services featuring pharmaceutical preparations; retail and wholesale store services featuring pharmaceutical preparations; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases | ACTIVE | — |
| 042 | Scientific research; technological research in the field of pharmaceuticals; technological research in the fields of genetics, genetic engineering, molecular biology and cellular immunology; conducting technical project studies, namely, conducting scientific feasibility studies; scientific laboratory services; research and development of new products for others; chemical analysis; chemical research; biological research; scientific research in the nature of conducting clinical trials for others; chemistry services in the nature of chemist services; chemistry services, namely, consultation, research and advice; none of the above related to the treatment or prevention of cardiovascular diseases | ACTIVE | — |
| 044 | Hospital services; medical assistance; nursing, medical; medical, physical rehabilitation and physical therapy services; alternative medicine services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; blood collection services, namely, collection and preservation of human blood; performing diagnosis of diseases; collection and preservation of human blood; genetic testing for medical purposes; behavioral analysis for medical purposes; rental of medical instruments and apparatus; stem cell therapy services; veterinary assistance; all of the foregoing featuring monoclonal antibodies, and none of the above related to the treatment or prevention of cardiovascular diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks owned by Zhuhai Trinomab Pharmaceutical Co., Ltd.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named TRINOMAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 24, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Dec 24, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 24, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Dec 24, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 24, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 29, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 1, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 1, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Nov 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 13, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 13, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 28, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 28, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 15, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 15, 2024 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 8, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 24, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 24, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 24, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 24, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 11, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 21, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 21, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 11, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 11, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 11, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 2, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 22, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 22, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 30, 2023 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Jun 28, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 28, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 27, 2023 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jun 10, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 29, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 23, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |